New technique could aid treatments for diseases that lead to paralysis
Scientists working to develop new treatments for neurodegenerative diseases have been stymied by the inability to grow human motor neurons in the lab. Motor neurons drive muscle contractions, and their damage underlies devastating diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy, both of which ultimately lead to paralysis and early death.
In new research, scientists at Washington University School of Medicine in St. Louis have converted skin cells from healthy adults directly into motor neurons without going through a stem cell state.
The technique makes it possible to study motor neurons of the human central nervous system in the lab. Unlike commonly studied mouse motor neurons, human motor neurons growing in the lab would be a new tool since researchers can’t take samples of these neurons from living people but can easily take skin samples.
The study is published Sept. 7 in the journal Cell Stem Cell.
Avoiding the stem cell phase eliminates ethical concerns raised when producing what are called pluripotent stem cells, which are similar to embryonic stem cells in their ability to become all adult cell types. And importantly, avoiding a stem cell state allows the resulting motor neurons to retain the age of the original skin cells and, therefore, the age of the patient. Maintaining the chronological age of these cells is vital when studying neurodegenerative diseases that develop in people at different ages and worsen over decades.
“In this study, we only used skin cells from healthy adults ranging in age from early 20s to late 60s,” said senior author Andrew S. Yoo, PhD, an assistant professor of developmental biology. “Our research revealed how small RNA molecules can work with other cell signals called transcription factors to generate specific types of neurons, in this case motor neurons. In the future, we would like to study skin cells from patients with disorders of motor neurons. Our conversion process should model late-onset aspects of the disease using neurons derived from patients with the condition.”
“Going back through a pluripotent stem cell phase is a bit like demolishing a house and building a new one from the ground up,” Yoo said. “What we’re doing is more like renovation. We change the interior but leave the original structure, which retains the characteristics of the aging adult neurons that we want to study.”
The ability of scientists to convert human skin cells into other cell types, such as neurons, has the potential to enhance understanding of disease and lead to finding new ways to heal damaged tissues and organs, a field called regenerative medicine.
To convert skin cells into motor neurons, the researchers exposed the skin cells to molecular signals that are usually present at high levels in the brain. Past work by Yoo and his colleagues — then at Stanford University — showed that exposure to two short snippets of RNA turned human skin cells into neurons. These two microRNAs — called miR-9 and miR-124 — are involved with repackaging the genetic instructions of the cell.
In the new study, the researchers extensively characterized this repackaging process, detailing how skin cells reprogrammed into generic neurons then can be guided into specific types of neurons. They found that genes involved in this process become poised for expression but remain inactive until the correct combination of molecules is provided. After much experimentation with multiple combinations, the researchers found that adding two more signals to the mix — transcription factors called ISL1 and LHX3 — turned the skin cells into spinal cord motor neurons in about 30 days.
The combination of signals — microRNAs miR-9 and miR-124 plus transcription factors ISL1 and LHX3 — tells the cell to fold up the genetic instructions for making skin and unfurl the instructions for making motor neurons, according to Yoo and the study’s co-first authors, Daniel G. Abernathy and Matthew J. McCoy, doctoral students in Yoo’s lab; and Woo Kyung Kim, PhD, a postdoctoral research associate.
Another past study from Yoo’s team showed that exposure to the same two microRNAs, miR-9 and miR-124, plus a different mix of transcription factors could turn skin cells into a different type of neuron. In that case, the skin cells became striatal medium spiny neurons, which are affected in Huntington’s disease — an inherited, eventually fatal genetic disorder that causes involuntary muscle movements and cognitive decline beginning in middle adulthood.
In the new study, the researchers said the converted motor neurons compared favorably to normal mouse motor neurons, in terms of the genes that are turned on and off and how they function. But the scientists can’t be certain these cells are perfect matches for native human motor neurons since it’s difficult to obtain samples of cultured motor neurons from adult individuals. Future work studying neuron samples donated from patients after death is required to determine how precisely these cells mimic native human motor neurons.
The Latest on: Neurodegenerative diseases
- Artificial Intelligence may be the key to identify neurodegenerative diseases' progresson February 2, 2020 at 4:09 pm
Montreal (Quebec) [Canada], Feb 2 (ANI): Artificial intelligence (AI) algorithms show the potential to predict neurodegenerative diseases progression among humans. This amalgamation of computer ...
- McGill University, The Neuro and Fuzionaire Diagnostics to Develop Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Diseaseon January 31, 2020 at 6:54 am
Fuzionaire Diagnostics, Inc. ("Fuzionaire Dx") today announced a collaborative research agreement with McGill University ("McGill") and The Neuro (Montreal Neurological Institute-Hospital). The collab ...
- Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinicon January 31, 2020 at 2:15 am
OCT biomarkers for AD should be subject to further longitudinal testing. The diagnosis of Alzheimer’s disease (AD), the most frequent neurodegenerative disease, requires clinical diagnostic criteria ...
- Rare disease biotech Passage Bio nabs Deerfield veteran as CEOon January 29, 2020 at 6:48 am
Those programs target rare pediatric disease GM1 gangliosidosis and neurodegenerative disorder frontotemporal dementia. Since the series A, Passage Bio has added a third program to its pipeline, ...
- AI-based blood tests to predict neurodegenerative disease progressionon January 28, 2020 at 8:32 pm
A recent study has shown the effectiveness of Artificial Intelligence (AI) algorithms in predicting the progression of neurodegenerative diseases in people. This amalgamation of computer science and ...
- New AI tool predicts disease progression and evolution in neurodegenerative disorderson January 28, 2020 at 6:45 am
Researchers at the Montreal Neurological Institute, Canada have found that testing blood using an artificial intelligence (AI) algorithm successfully predicted disease progression in neurodegenerative ...
- AI-Based Blood Test Predicts Neurodegenerative Disease Progressionon January 28, 2020 at 5:38 am
The progression of a neurodegenerative disease is slow—possibly taking decades to develop—patient-specific, and can be conflated with other aging processes. In addition, there are gaps in the ...
- AI-analyzed blood test can predict the progression of neurodegenerative diseaseon January 28, 2020 at 12:53 am
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient's progression is different. A new study shows artificial intelligence (AI) analysis of ...
- How Neurodegenerative Diseases are Affected by Gamma Synuclein Aggregationon January 27, 2020 at 11:45 pm
1-4 Lewy bodies can form through aggregation of alpha synuclein. This has also been linked to neurodegenerative disorders such Parkinson’s Disease (PD). Alpha synuclein aggregation is inhibited by ...
- Unexpected connection between gliomas, neurodegenerative diseaseson January 23, 2020 at 8:09 am
A protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a type of cancerous brain tumor, become so aggressive. The new study, in ...
via Google News and Bing News